CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: March 8, 2013
Result type: Reports
Project Number: SR0316-000
Product Line: Common Drug Review

Generic Name: Perampanel

Brand Name: Fycompa

Manufacturer: Eisai Ltd.

Indications: Epilepsy, partial onset seizures

Submission Type: Pre-NOC

Project Status: Complete

Date Recommendation Issued: October 17, 2013

Recommendation Type: List with criteria/condition